|
시장보고서
상품코드
2105112
피부과용 의료기기 시장 : 유형별, 용도별, 기술별, 최종사용자별, 지역별 - 세계 예측(-2031년)Dermatology Devices Market by Type (Diagnostic ), Treatment, Application, Technology, End User, Region - Global Forecast to 2031 |
||||||
피부과용 의료기기 시장 규모는 2026년에 약 93억 2,000만 달러 규모에 달하고, 2031년까지 177억 3,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 CAGR은 13.7%를 기록할 전망입니다.
피부암, 여드름, 건선, 색소 침착 장애 등 피부 질환의 유병률 증가에 더해, 최소침습 및 비침습적 미용 시술에 대한 수요가 높아지면서 첨단 피부과용 의료기기의 보급이 가속화되고 있습니다.
| 조사 범위 | |
|---|---|
| 조사 대상 기간 | 2024-2031년 |
| 기준 연도 | 2025년 |
| 예측 기간 | 2026-2031년 |
| 산정 단위 | 금액(10억 달러) |
| 부문 | 유형별, 용도별, 기술별, 최종사용자별, 지역별 |
| 대상 지역 | 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카 |
레이저, 고주파, HIFU, 광치료 및 영상 진단 기술의 지속적인 발전으로 치료의 정밀도, 안전성 및 임상 성과가 향상되고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다. 고령화의 진행, 소셜 미디어의 영향으로 인한 미용 의식의 고조, 가처분 소득의 증가, 그리고 피부과 클리닉 및 미용 클리닉의 확대도 전 세계 피부과용 의료기기의 보급에 기여하고 있습니다.
"예측 기간 동안 진단 기기 유형별로 볼 때, 피부과용 의료기기 시장에서 영상 진단 기기 부문이 가장 높은 성장률을 보일 것으로 예상됩니다."
진단 기기의 종류에 따라, 피부과용 의료기기 시장은 영상 진단 기기, 피부경, 현미경으로 분류됩니다. 예측 기간 동안 영상 진단 기기 부문은 피부과용 의료기기 시장에서 가장 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 이러한 성장은 주로 피부 질환의 조기 발견, 진단 및 경과 관찰을 위한 첨단 비침습적 영상 진단 기술의 채택 확대에 의해 주도되고 있습니다. 광간섭 단층촬영(OCT), 고주파 초음파(HFUS) 및 기타 고해상도 영상 진단 시스템의 활용이 확대됨에 따라 피부 구조의 실시간 시각화가 가능해져 진단 정확도가 향상될 뿐만 아니라, 많은 사례에서 침습적인 생검의 필요성이 줄어들고 있습니다. 또한, 지속적인 기술 발전, 피부암 및 기타 피부 질환의 발생률 증가, 정밀한 영상 유도 진단에 대한 수요 증가, 그리고 피부과 클리닉 및 병원에서의 첨단 진단 기술 도입 확대가 예측 기간 동안 이 부문의 급속한 성장을 견인할 것으로 전망됩니다.
"2025년 시점에서 유형별로 보면 치료용 기기 부문이 피부과용 의료기기 시장에서 가장 큰 점유율을 차지했습니다."
유형별로 보면 피부과용 의료기기 시장은 진단용 기기와 치료용 기기로 분류됩니다. 2025년에는 치료용 기기 부문이 피부과용 의료기기 시장에서 가장 큰 점유율을 차지했습니다. 이러한 우위는 미용 및 치료를 목적으로 한 피부과 시술에 대한 수요 증가, 여드름, 건선, 피부암, 색소 침착 장애 등 만성 및 미용적 피부 질환의 유병률 증가, 그리고 최소침습 및 비침습적 치료법 선택이 선호되는 경향이 강해지고 있기 때문입니다. 또한, 레이저, 고주파, HIFU, 냉동요법 및 기타 에너지 기반 기술의 지속적인 발전으로 치료의 정밀도, 안전성 및 임상 결과가 향상되어 이러한 기술들이 널리 채택되고 있습니다. 피부과 및 미용 클리닉 네트워크의 확대, 미용 치료에 대한 소비자의 인식 제고, 가처분 소득의 증가, 그리고 미용 시술에 대한 수용도 상승이 치료용 기기 부문의 성장을 더욱 뒷받침하고 있습니다.
"예측 기간 동안 아시아태평양은 피부과용 의료기기 시장에서 가장 빠른 성장을 이룰 것으로 예상됩니다."
지역별로 보면 피부과용 의료기기 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분류됩니다. 예측 기간 동안 아시아태평양은 피부과용 의료기기 시장에서 가장 높은 연평균 성장률(CAGR)을 기록할 것으로 전망됩니다. 이러한 성장은 주로 중국, 인도, 인도네시아, 태국 등 신흥 경제국들의 급속한 경제 발전, 가처분 소득 증가, 그리고 의료 접근성 확대에 의해 주도되고 있습니다. 이 지역의 대규모이며 증가 추세에 있는 인구, 피부 질환 유병률의 상승, 피부과 및 미용 치료에 대한 인식 제고, 그리고 최소침습 치료에 대한 수요 확대가 시장 성장을 더욱 뒷받침하고 있습니다. 또한, 중산층의 확대, 의료 인프라에 대한 투자 증가, 피부과·미용 클리닉의 급속한 증가, 첨단 피부과 기술의 지속적인 도입, 그리고 한국이나 태국 등 국가에서의 의료 관광 인기 상승이 예측 기간 동안 아시아태평양 피부과용 의료기기 시장의 성장을 가속화할 것으로 전망됩니다.
피부과용 의료기기 시장의 주요 기업으로는 Bausch Health Companies Inc.(캐나다), Sisram Medical Ltd.(이스라엘), AbbVie Inc.(미국), InMode Ltd.(이스라엘), BTL Group of Companies(체코), El.En. S.p.A.(이탈리아), Cutera, Inc.(미국), Lumenis Be Ltd.(이스라엘), Cynosure Lutronic(미국), Candela Corporation(미국), Jeisys Medical Inc.(한국), HEINE Optotechnik GmbH & Co. KG(독일), Canfield Scientific, Inc.(미국), Michelson Diagnostics(영국), Genesis Biosystems, Inc.(미국), FotoFinder Systems GmbH(독일), Beijing Toplaser Technology(중국), Aerolase(미국), GIGAAMEDICAL(중국), Dimed Laser(중국), Sciton(미국), Fotona(미국), Lynton Lasers Ltd.(영국), Astanza Laser(미국), 및 Courage+Khazaka electronic GmbH(독일) 등이 있습니다.
조사 범위:
본 조사 보고서에서는 피부과용 의료기기 시장을 유형별 [진단 기기(영상 진단 장치, 피부경, 현미경), 치료 기기(광선요법 장치, 레이저, 전기 수술 기기, 지방 흡입 장치, 마이크로더마브레이션 장치, 냉동요법 장치, 고주파 장치 및 HIFU(고밀도 집속 초음파) 기기)], 용도별 [진단 용도(피부암 진단, 염증성 피부 질환 진단, 모발·두피 질환 진단 및 기타 진단 용도), 의료 치료 용도(피부암 치료, 여드름·건선 치료, 혈관성·색소성 병변 치료 및 기타 의료 치료 용도), 미용 치료 용도(제모, 피부 회춘·안티에이징, 주름 제거·피부 재생, 바디 컨투어링·지방 제거, 문신 제거 및 기타 미용 치료 용도)], 기술별(레이저 방식, 초음파 방식, 광학 방식, 냉동요법 방식, RF(고주파) 기반, 및 기타 기술), 최종사용자별(병원, 피부과 클리닉·의료 시설, 미용 살롱 및 재택 케어 환경), 그리고 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)로 분류되어 있습니다. 본 보고서는 피부과용 의료기기 시장의 성장을 좌우하는 주요 촉진요인, 억제요인, 기회 및 과제에 대한 종합적인 개요를 제공합니다. 또한 주요 업계 플레이어에 대해 비즈니스 모델, 솔루션, 주요 전략, 최근 인수 및 계약에 초점을 맞춘 상세한 분석을 수행하고 있습니다. 아울러, 피부과용 의료기기 시장에 진출한 신생 스타트업 기업들의 경쟁 분석도 포함되어 있습니다.
본 보고서를 구매해야 하는 이유:
본 보고서는 피부과용 의료기기 업계의 시장 리더 및 신규 진입 기업에게 시장 전체 및 그 하위 부문의 추정 매출 데이터를 제공함으로써 지원을 제공합니다. 이해관계자가 경쟁 구도를 이해하고, 자사의 비즈니스를 보다 효과적으로 포지셔닝하며, 적절한 시장 진입 전략을 수립할 수 있도록 돕는 것을 목적으로 합니다. 또한, 본 보고서는 주요 시장 촉진요인, 제약요인, 기회, 과제를 포함한 시장 역학에 대한 인사이트를 제공합니다.
본 보고서는 다음 사항에 대한 인사이트를 제공합니다:
- 주요 촉진요인(피부 질환 및 피부암 유병률 증가, 최소침습 및 비침습적 미용 시술에 대한 수요 증가, 고령화 진행 및 노화에 따른 피부 질환 부담 증가, 미용 의식 고조, 소셜 미디어의 영향, 외모 중시)에 대한 분석, 제약요인(의료기기에 대한 엄격한 규제 요건, 시술과 관련된 유해 사건 및 합병증의 위험), 기회(신흥 시장에서의 피부과 서비스 확대, 가처분 소득 증가 및 중산층 확대), 그리고 과제(저비용 제조사 간의 가격 경쟁, 첨단 피부과용 의료기기의 높은 비용, 미용 시술에 대한 보험 급여 제한) 등, 피부과용 의료기기 시장의 성장에 영향을 미치는 요인에 대해
- 제품 개발 및 혁신 : 피부과용 의료기기 시장의 향후 기술 동향, 연구개발 활동 및 신제품 출시에 관한 상세한 분석
- 시장 개발 : 수익성이 높은 시장에 대한 종합적인 정보. 본 보고서에서는 다양한 지역의 피부과용 의료기기 시장을 분석
- 시장 다각화 : 피부과용 의료기기 시장의 신제품, 미개척 지역, 최근 동향 및 투자에 관한 종합적인 정보
- 경쟁 분석 : Bausch Health Companies Inc.(캐나다), Sisram Medical Ltd(이스라엘), Lumenis Be Ltd.(이스라엘), InMode Ltd.(이스라엘), BTL Group of Companies(체코)와 같은 주요 기업의 시장 점유율, 성장 전략, 제품 라인업에 대한 상세한 평가
목차
제1장 소개
제2장 주요 요약
제3장 주요 인사이트
제4장 시장 개요
제5장 업계 동향
제6장 기술 진보, AI에 의한 영향, 특허, 혁신, 그리고 향후 응용
제7장 규제 상황과 지속가능성
제8장 고객 상황과 구매 행동
제9장 피부과 진단 기기 시장(유형별)
제10장 피부과용 의료기기 시장(용도별)
제11장 피부과용 의료기기 시장(기술별)
제12장 피부과용 의료기기 시장(최종사용자별)
제13장 피부과용 의료기기 시장(지역별)
제14장 경쟁 구도
제15장 기업 개요
제16장 조사 방법
제17장 부록
KSMThe dermatology devices market is valued at around USD 9.32 billion in 2026 and is expected to reach USD 17.73 billion by 2031, reflecting a CAGR of 13.7% over the forecast period. The rising prevalence of skin disorders, including skin cancer, acne, psoriasis, and pigmentation disorders, along with growing demand for minimally invasive and non-invasive aesthetic procedures, is driving adoption of advanced dermatology devices.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Type, Application, Technology, and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Ongoing advancements in laser, radiofrequency, HIFU, light-based, and imaging technologies are improving treatment precision, safety, and clinical outcomes, further supporting market growth. The growing aging population, increasing beauty consciousness influenced by social media, rising disposable incomes, and the expansion of dermatology clinics and aesthetic centers are also contributing to the adoption of dermatology devices worldwide.
"The imaging devices segment is expected to witness the fastest growth rate in the dermatology devices market, by diagnostic device type, during the forecast period."
Based on diagnostic device type, the dermatology devices market is segmented into imaging devices, dermatoscopes, and microscopes. During the forecast period, the imaging devices segment is expected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by the increasing adoption of advanced, non-invasive imaging technologies for the early detection, diagnosis, and monitoring of skin disorders. The growing use of optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and other high-resolution imaging systems enables real-time visualization of skin structures, improving diagnostic accuracy while reducing the need for invasive biopsies in many cases. Furthermore, continuous technological advancements, the rising incidence of skin cancer and other dermatological conditions, increasing demand for precise image-guided diagnosis, and growing adoption of advanced diagnostic technologies in dermatology clinics and hospitals are expected to drive rapid growth in this segment during the forecast period.
"The treatment devices segment accounted for the largest share of the dermatology devices market, by type, in 2025."
By type, the dermatology devices market is segmented into diagnostic and treatment devices. In 2025, the treatment devices segment accounted for the largest share of the dermatology devices market. This dominance is driven by rising demand for both aesthetic and therapeutic dermatology procedures, the growing prevalence of chronic and cosmetic skin conditions such as acne, psoriasis, skin cancer, and pigmentation disorders, and a growing preference for minimally invasive and non-invasive treatment options. Additionally, ongoing advances in laser, radiofrequency, HIFU, cryotherapy, and other energy-based technologies have improved treatment precision, safety, and clinical outcomes, leading to their widespread adoption. The expanding network of dermatology and cosmetic clinics, growing consumer awareness of aesthetic treatments, rising disposable incomes, and increasing acceptance of cosmetic procedures are further supporting the growth of the treatment devices segment.
"The Asia Pacific region is expected to witness the fastest growth in the dermatology devices market during the forecast period."
By region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia Pacific is projected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by rapid economic development, rising disposable incomes, and expanding access to healthcare across emerging economies such as China, India, Indonesia, and Thailand. The region's large and growing population, increasing prevalence of skin disorders, rising awareness of dermatological and aesthetic treatments, and growing demand for minimally invasive procedures further support market growth. Furthermore, the expanding middle-class population, increasing investments in healthcare infrastructure, rapid growth in dermatology and aesthetic clinics, continuous adoption of advanced dermatology technologies, and the growing popularity of medical tourism in countries such as South Korea and Thailand are expected to accelerate growth in the Asia Pacific dermatology devices market during the forecast period.
The breakup of the profile of primary participants in the dermatology devices market:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%)
- By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
The key players in the dermatology devices market include Bausch Health Companies Inc. (Canada), Sisram Medical Ltd. (Israel), AbbVie Inc. (US), InMode Ltd. (Israel), BTL Group of Companies (Czech Republic), El.En. S.p.A. (Italy), Cutera, Inc. (US), Lumenis Be Ltd. (Israel), Cynosure Lutronic (US), Candela Corporation (US), Jeisys Medical Inc. (South Korea), HEINE Optotechnik GmbH & Co. KG (Germany), Canfield Scientific, Inc. (US), Michelson Diagnostics (UK), Genesis Biosystems, Inc. (US), FotoFinder Systems GmbH (Germany), Beijing Toplaser Technology Co., Ltd. (China), Aerolase (US), GIGAAMEDICAL (China), Dimed Laser (China), Sciton (US), Fotona (US), Lynton Lasers Ltd. (UK), Astanza Laser (US), and Courage+Khazaka electronic GmbH (Germany).
Research Coverage:
This research report categorizes the dermatology devices market by Type [Diagnostic Devices (Imaging Devices, Dermatoscopes, and Microscopes), Treatment Devices (Light Therapy Devices, Lasers, Electrosurgical Equipment, Liposuction Devices, Microdermabrasion Devices, Cryotherapy Devices, Radiofrequency Devices, and HIFU (High-Intensity Focused Ultrasound) Devices)], by Application [Diagnostic Applications (Skin Cancer Diagnosis, Inflammatory Skin Disease Diagnosis, Hair & Scalp Disorder Diagnosis, and Other Diagnostic Applications), Medical Therapeutic Applications (Skin Cancer Treatment, Acne & Psoriasis Treatment, Vascular & Pigmented Lesion Treatment, and Other Medical Therapeutic Applications), and Aesthetic Therapeutic Applications (Hair Removal, Skin Rejuvenation & Anti-aging, Wrinkle Removal & Skin Resurfacing, Body Contouring & Fat Removal, Tattoo Removal, and Other Aesthetic Therapeutic Applications)], by Technology (Laser-Based, Ultrasound-Based, Light-Based, Cryotherapy-Based, RF-Based, and Other Technologies), by End User (Hospitals, Dermatology Clinics & Medical Facilities, Beauty Centers, and Home Care Settings), and by Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides a comprehensive overview of the key drivers, restraints, opportunities, and challenges shaping growth in the dermatology devices market. It offers an in-depth analysis of the major industry players, highlighting their business models, solutions, key strategies, recent acquisitions, and agreements. Additionally, the report includes a competitive analysis of emerging startups in the dermatology devices market.
Reasons to Buy this Report:
The report will assist market leaders and new entrants in the dermatology devices industry by providing estimated revenue figures for the overall market and its subsegments. It aims to help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (rising prevalence of skin disorders and skin cancer, increasing demand for minimally invasive and noninvasive aesthetic procedures, growing aging population and rising burden of age-related skin conditions, and growing beauty consciousness, social media influence, and emphasis on personal appearance), restraints (stringent regulatory requirements for medical devices, risk of procedure-related adverse events and complications), opportunities (expansion of dermatology services in emerging markets, increasing disposable income and expanding middle-class population), and challenges (competitive pricing by low-cost manufacturers, high cost of advanced dermatology devices and limited reimbursement for aesthetic procedures) influencing the growth of the dermatology devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the dermatology devices market
- Market Development: Comprehensive information about lucrative markets; the report analyzes the dermatology devices market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the dermatology devices market
- Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Bausch Health Companies Inc. (Canada), Sisram Medical Ltd (Israel), Lumenis Be Ltd. (Israel), InMode Ltd. (Israel), and BTL Group of Companies (Czech Republic)
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
- 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS SHAPING MARKET
- 2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
- 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 DERMATOLOGY DEVICES MARKET OVERVIEW
- 3.2 DERMATOLOGY DEVICES MARKET, BY TYPE, 2026 VS. 2031
- 3.3 DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2026 VS. 2031
- 3.4 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2026 VS. 2031
- 3.5 DERMATOLOGY DEVICES MARKET, BY END USER, 2026 VS. 2031
- 3.6 DERMATOLOGY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising prevalence of skin disorders and skin cancer
- 4.2.1.2 Increasing demand for minimally invasive and non-invasive aesthetic procedures
- 4.2.1.3 Growing aging population and rising burden of age-related skin conditions
- 4.2.1.4 Growing beauty consciousness, social media influence, and emphasis on personal appearance
- 4.2.2 RESTRAINTS
- 4.2.2.1 Stringent regulatory requirements for medical devices
- 4.2.2.2 Risk of procedure-related adverse events and complications
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expansion of dermatology services in emerging markets
- 4.2.3.2 Increasing disposable income and expanding middle-class population
- 4.2.4 CHALLENGES
- 4.2.4.1 Competitive pricing by low-cost manufacturers
- 4.2.4.2 High cost of advanced dermatology devices and limited reimbursement for aesthetic procedures
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN DERMATOLOGY DEVICES MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
- 4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF SUPPLIERS
- 5.1.2 BARGAINING POWER OF BUYERS
- 5.1.3 THREAT OF NEW ENTRANTS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 DERMATOLOGY DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY KEY PLAYER, 2024-2026
- 5.6.2 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY REGION, 2024-2026
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT SCENARIO (HS CODE 901320)
- 5.7.2 EXPORT SCENARIO (HS CODE 901320)
- 5.8 KEY CONFERENCES & EVENTS, 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.10 INVESTMENT & FUNDING SCENARIO
- 5.11 IMPACT OF 2025 US TARIFF ON DERMATOLOGY DEVICES MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON REGION
- 5.11.4.1 North America
- 5.11.4.2 Europe
- 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 LASER TECHNOLOGIES
- 6.1.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 TELEDERMATOLOGY PLATFORMS
- 6.2.2 ADVANCED CRYOGEN COOLING & SKIN COOLING TECHNOLOGIES
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 OPTICAL COHERENCE TOMOGRAPHY (OCT)
- 6.3.2 3D SKIN IMAGING & COMPUTER VISION
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.5 PATENT ANALYSIS
- 6.5.1 LIST OF MAJOR PATENTS
- 6.5.2 LIST OF KEY PATENTS
- 6.6 FUTURE APPLICATIONS
- 6.7 IMPACT OF AI/GENERATIVE AI ON DERMATOLOGY DEVICES MARKET
- 6.7.1 INTRODUCTION
- 6.7.2 TOP USE CASES AND MARKET POTENTIAL
- 6.7.3 KEY COMPANIES IMPLEMENTING AI
- 6.7.4 FUTURE OF AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN DERMATOLOGY DEVICES
- 7.2.1.1 Eco-friendly Initiatives
- 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN DERMATOLOGY DEVICES
- 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
- 8.5.1 REVENUE POTENTIAL
- 8.5.2 COST DYNAMICS
- 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE
- 9.1 INTRODUCTION
- 9.2 DIAGNOSTIC DEVICES
- 9.2.1 IMAGING DEVICES
- 9.2.1.1 MRI, Ultrasound, CT, and OCT widely used in dermatology disease diagnosis
- 9.2.2 DERMATOSCOPES
- 9.2.2.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH
- 9.2.3 MICROSCOPES
- 9.2.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES - KEY FACTOR DRIVING SEGMENT GROWTH
- 9.2.1 IMAGING DEVICES
- 9.3 TREATMENT DEVICES
- 9.3.1 LIGHT THERAPY DEVICES
- 9.3.1.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES TO DRIVE SEGMENT GROWTH
- 9.3.2 LASERS
- 9.3.2.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS
- 9.3.3 ELECTROSURGICAL EQUIPMENT
- 9.3.3.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH
- 9.3.4 LIPOSUCTION DEVICES
- 9.3.4.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH
- 9.3.5 MICRODERMABRASION DEVICES
- 9.3.5.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH
- 9.3.6 CRYOTHERAPY DEVICES
- 9.3.6.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ADOPTION
- 9.3.7 RADIOFREQUENCY DEVICES
- 9.3.7.1 Rising demand for minimally invasive skin rejuvenation driving RF devices segment
- 9.3.8 HIFU DEVICES
- 9.3.8.1 Growing demand for non-invasive skin lifting driving HIFU devices growth
- 9.3.9 OTHER DERMATOLOGY TREATMENT DEVICES
- 9.3.1 LIGHT THERAPY DEVICES
10 DERMATOLOGY DEVICES MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 DIAGNOSTIC APPLICATION
- 10.2.1 SKIN CANCER DIAGNOSIS
- 10.2.1.1 Growing emphasis on early melanoma detection to drive skin cancer diagnosis segment
- 10.2.2 INFLAMMATORY SKIN DISEASE DIAGNOSIS
- 10.2.2.1 Increasing prevalence of chronic inflammatory skin disorders to support market growth
- 10.2.3 HAIR & SCALP DISORDER DIAGNOSIS
- 10.2.3.1 Rising awareness of hair health and increasing cases of hair loss to drive demand
- 10.2.4 OTHER DIAGNOSTIC APPLICATIONS
- 10.2.1 SKIN CANCER DIAGNOSIS
- 10.3 MEDICAL THERAPEUTIC APPLICATIONS
- 10.3.1 SKIN CANCER TREATMENT
- 10.3.1.1 Increasing adoption of minimally invasive therapies to drive demand
- 10.3.2 ACNE & PSORIASIS TREATMENT
- 10.3.2.1 Growing preference for long-term, minimally invasive disease management to support market growth
- 10.3.3 VASCULAR & PIGMENTED LESION TREATMENT
- 10.3.3.1 Rising demand for precise cosmetic correction to accelerate device adoption
- 10.3.4 OTHER MEDICAL THERAPEUTIC APPLICATIONS
- 10.3.1 SKIN CANCER TREATMENT
- 10.4 AESTHETIC THERAPEUTIC APPLICATIONS
- 10.4.1 HAIR REMOVAL
- 10.4.1.1 Long-lasting results continue to shift consumers toward laser-based hair removal
- 10.4.2 SKIN REJUVENATION & ANTI-AGING
- 10.4.2.1 Growing appearance consciousness and preventive aesthetic care to reshape treatment demand
- 10.4.3 WRINKLE REMOVAL & SKIN RESURFACING
- 10.4.3.1 Preference for visible results without surgery to accelerate procedure adoption
- 10.4.4 BODY CONTOURING & FAT REMOVAL
- 10.4.4.1 Growing body confidence trends to increase demand for non-surgical body sculpting
- 10.4.5 TATTOO REMOVAL
- 10.4.5.1 Changing lifestyle preferences and advances in laser technology to drive procedure demand
- 10.4.6 OTHER AESTHETIC THERAPEUTIC APPLICATIONS
- 10.4.1 HAIR REMOVAL
11 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY
- 11.1 INTRODUCTION
- 11.2 LASER-BASED
- 11.2.1 HIGH PRECISION AND BROAD CLINICAL APPLICATIONS TO DRIVE LASER-BASED SEGMENT
- 11.3 ULTRASOUND-BASED
- 11.3.1 INCREASING ADOPTION OF NON-INVASIVE SKIN LIFTING PROCEDURES TO DRIVE ULTRASOUND-BASED SEGMENT
- 11.4 LIGHT-BASED
- 11.4.1 EXPANDING USE OF NON-LASER LIGHT THERAPIES TO SUPPORT LIGHT-BASED SEGMENT
- 11.5 CRYOTHERAPY-BASED
- 11.5.1 INCREASING PREFERENCE FOR RAPID, OFFICE-BASED LESION TREATMENT TO SUPPORT SEGMENT
- 11.6 RF-BASED
- 11.6.1 ADVANCEMENTS IN COLLAGEN REMODELING TECHNOLOGIES TO DRIVE RF-BASED SEGMENT
- 11.7 OTHER TECHNOLOGIES
12 DERMATOLOGY DEVICES MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES
- 12.2.1 INCREASING PATIENT PREFERENCE FOR SPECIALIZED DERMATOLOGY CARE TO DRIVE GROWTH OF SEGMENT
- 12.3 BEAUTY CENTERS
- 12.3.1 GROWING CONSUMER DEMAND FOR NON-INVASIVE AESTHETIC PROCEDURES TO DRIVE BEAUTY CENTERS SEGMENT
- 12.4 HOME CARE SETTINGS
- 12.4.1 GROWING AVAILABILITY OF PORTABLE AND EASY-TO-USE DEVICES TO SUPPORT THIS SEGMENT
13 DERMATOLOGY DEVICES MARKET, BY REGION
- 13.1 INTRODUCTION
- 13.2 NORTH AMERICA
- 13.2.1 US
- 13.2.1.1 High healthcare expenditure and technological innovation to drive market growth
- 13.2.2 CANADA
- 13.2.2.1 Growing aging population and preference for minimally invasive procedures driving market growth
- 13.2.1 US
- 13.3 EUROPE
- 13.3.1 GERMANY
- 13.3.1.1 Increasing demand for minimally invasive dermatology procedures to drive market growth
- 13.3.2 UK
- 13.3.2.1 Increasing skin cancer incidence to drive market growth
- 13.3.3 FRANCE
- 13.3.3.1 Growing social acceptance of medical aesthetic treatments to drive market growth
- 13.3.4 ITALY
- 13.3.4.1 Growing medical tourism for aesthetic procedures to drive market growth
- 13.3.5 SPAIN
- 13.3.5.1 Increasing preference for minimally invasive aesthetic treatments to drive market growth
- 13.3.6 REST OF EUROPE
- 13.3.1 GERMANY
- 13.4 ASIA PACIFIC
- 13.4.1 CHINA
- 13.4.1.1 Increasing availability of digital aesthetic consultation platforms to drive market growth
- 13.4.2 JAPAN
- 13.4.2.1 Growing demand for non-surgical aesthetic procedures to drive market growth
- 13.4.3 INDIA
- 13.4.3.1 Rising awareness and affordability of aesthetic treatments to drive market growth
- 13.4.4 REST OF ASIA PACIFIC
- 13.4.1 CHINA
- 13.5 LATIN AMERICA
- 13.5.1 BRAZIL
- 13.5.1.1 Expanding medical tourism to drive market growth
- 13.5.2 MEXICO
- 13.5.2.1 Expanding medical aesthetics industry to drive market growth
- 13.5.3 REST OF LATIN AMERICA
- 13.5.1 BRAZIL
- 13.6 MIDDLE EAST & AFRICA
14 COMPETITIVE LANDSCAPE
- 14.1 INTRODUCTION
- 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DERMATOLOGY DEVICES MARKET
- 14.3 REVENUE ANALYSIS, 2023-2025
- 14.4 MARKET SHARE ANALYSIS, 2025
- 14.4.1 MARKET SHARE ANALYSIS, 2025
- 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 14.5.1 STARS
- 14.5.2 EMERGING LEADERS
- 14.5.3 PERVASIVE PLAYERS
- 14.5.4 PARTICIPANTS
- 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 14.5.5.1 Company footprint
- 14.5.5.2 Region footprint
- 14.5.5.3 Type footprint
- 14.5.5.4 Application footprint
- 14.5.5.5 End user footprint
- 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 14.6.1 PROGRESSIVE COMPANIES
- 14.6.2 RESPONSIVE COMPANIES
- 14.6.3 DYNAMIC COMPANIES
- 14.6.4 STARTING BLOCKS
- 14.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 14.6.5.1 Detailed list of key startups/SMEs
- 14.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
- 14.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
- 14.7 COMPANY VALUATION & FINANCIAL METRICS
- 14.7.1 FINANCIAL METRICS
- 14.7.2 COMPANY VALUATION
- 14.8 BRAND/PRODUCT COMPARISON
- 14.9 COMPETITIVE SCENARIO
- 14.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
- 14.9.2 DEALS
- 14.9.2.1 Expansions
15 COMPANY PROFILES
- 15.1 KEY PLAYERS
- 15.1.1 BAUSCH HEALTH COMPANIES INC.
- 15.1.1.1 Business overview
- 15.1.1.2 Products offered
- 15.1.1.3 Recent developments
- 15.1.1.3.1 Product launches & approvals
- 15.1.1.3.2 Deals
- 15.1.1.4 MnM view
- 15.1.1.4.1 Right to win
- 15.1.1.4.2 Strategic choices
- 15.1.1.4.3 Weaknesses & competitive threats
- 15.1.2 SISRAM MEDICAL LTD
- 15.1.2.1 Business overview
- 15.1.2.2 Products offered
- 15.1.2.3 Recent developments
- 15.1.2.3.1 Product launches & approvals
- 15.1.2.4 MnM view
- 15.1.2.4.1 Right to win
- 15.1.2.4.2 Strategic choices
- 15.1.2.4.3 Weaknesses & competitive threats
- 15.1.3 LUMENIS BE LTD.
- 15.1.3.1 Business overview
- 15.1.3.2 Products offered
- 15.1.3.3 Recent developments
- 15.1.3.3.1 Product launches & approvals
- 15.1.3.3.2 Deals
- 15.1.3.4 MnM view
- 15.1.3.4.1 Right to win
- 15.1.3.4.2 Strategic choices
- 15.1.3.4.3 Weaknesses & competitive threats
- 15.1.4 INMODE LTD
- 15.1.4.1 Business overview
- 15.1.4.2 Products offered
- 15.1.4.3 Recent developments
- 15.1.4.3.1 Product launches & approvals
- 15.1.4.4 MnM view
- 15.1.4.4.1 Right to win
- 15.1.4.4.2 Strategic choices
- 15.1.4.4.3 Weaknesses & competitive threats
- 15.1.5 BTL GROUP OF COMPANIES
- 15.1.5.1 Business overview
- 15.1.5.2 Products offered
- 15.1.5.3 MnM view
- 15.1.5.3.1 Right to win
- 15.1.5.3.2 Strategic choices
- 15.1.5.3.3 Weaknesses & competitive threats
- 15.1.6 EL.EN. S.P.A.
- 15.1.6.1 Business overview
- 15.1.6.2 Products offered
- 15.1.6.3 Recent developments
- 15.1.6.3.1 Product launches & approvals
- 15.1.7 ABBVIE INC.
- 15.1.7.1 Business overview
- 15.1.7.2 Products offered
- 15.1.7.3 Recent developments
- 15.1.7.3.1 Product launches & approvals
- 15.1.8 CYNOSURE LUTRONIC
- 15.1.8.1 Business overview
- 15.1.8.2 Products offered
- 15.1.8.3 Recent developments
- 15.1.8.3.1 Product launches & approvals
- 15.1.8.3.2 Deals
- 15.1.9 CUTERA, INC.
- 15.1.9.1 Business overview
- 15.1.9.2 Products offered
- 15.1.9.3 Recent developments
- 15.1.9.3.1 Product launches & approvals
- 15.1.10 FOTONA
- 15.1.10.1 Business overview
- 15.1.10.2 Products offered
- 15.1.10.3 Recent developments
- 15.1.10.3.1 Expansions
- 15.1.1 BAUSCH HEALTH COMPANIES INC.
- 15.2 OTHER PLAYERS
- 15.2.1 CANDELA CORPORATION
- 15.2.2 JEISYS MEDICAL INC.
- 15.2.3 AEROLASE
- 15.2.4 SCITON
- 15.2.5 ASTANZA LASER
- 15.2.6 HEINE OPTOTECHNIK GMBH & CO. KG
- 15.2.7 CANFIELD SCIENTIFIC, INC.
- 15.2.8 MICHELSON DIAGNOSTICS
- 15.2.9 GENESIS BIOSYSTEMS, INC
- 15.2.10 FOTOFINDER SYSTEMS GMBH
- 15.2.11 BEIJING TOPLASER TECHNOLOGY CO., LTD.
- 15.2.12 GIGAAMEDICAL
- 15.2.13 DIMED LASER
- 15.2.14 LYNTON LASERS LTD
- 15.2.15 COURAGE+KHAZAKA ELECTRONIC GMBH
16 RESEARCH METHODOLOGY
- 16.1 RESEARCH DATA
- 16.2 SECONDARY DATA
- 16.2.1 LIST OF SECONDARY SOURCES
- 16.2.1.1 Key data from secondary sources
- 16.2.2 PRIMARY DATA
- 16.2.2.1 List of primary sources
- 16.2.2.2 Key data from primary sources
- 16.2.2.3 Key industry insights
- 16.2.2.4 Breakdown of primary interviews
- 16.2.1 LIST OF SECONDARY SOURCES
- 16.3 MARKET SIZE ESTIMATION
- 16.3.1 TOTAL MARKET SIZE: DERMATOLOGY DEVICE MARKET
- 16.3.2 BOTTOM-UP APPROACH
- 16.3.2.1 Approach 1: Revenue estimation of key players
- 16.3.2.2 Approach 2: Study of annual reports and investor presentations
- 16.3.2.3 Approach 3: Primary interviews
- 16.3.2.4 Growth forecast
- 16.3.2.5 CAGR projections
- 16.3.3 TOP-DOWN APPROACH
- 16.4 DATA TRIANGULATION
- 16.5 RESEARCH ASSUMPTIONS
- 16.5.1 STUDY-RELATED ASSUMPTIONS
- 16.6 STUDY ASSUMPTIONS
- 16.6.1 PARAMETRIC ASSUMPTIONS
- 16.6.2 GROWTH RATE ASSUMPTIONS
- 16.7 RESEARCH LIMITATIONS
- 16.8 RISK ASSESSMENT
17 APPENDIX
- 17.1 DISCUSSION GUIDE
- 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 17.3 CUSTOMIZATION OPTIONS
- 17.4 RELATED REPORTS
- 17.5 AUTHOR DETAILS
